Real-time enrollment status for this age-related macular degeneration clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 12:55 PM UTC
| NCT Number | NCT07064759 |
| Recruiting Status | Recruiting |
| Condition | Age-Related Macular Degeneration |
| Phase | PHASE3 |
| Target Enrollment | 480 participants |
| Active Locations | 54 sites in the US |
| Sponsor | 4D Molecular Therapeutics |
| Last Updated on CT.gov | April 16, 2026 (Apr 16, 2026) |
As of July 20, 2026: Clinical trial NCT07064759 is currently recruiting participants. This phase3 study for age-related macular degeneration is actively seeking new participants at 54 locations across the United States. The study is sponsored by 4D Molecular Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07064759 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 54 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07064759 was last updated Apr 16, 2026 (April 16, 2026). HelloStudys verifies this status automatically.